Navco Pharmaceuticals (TSXV:NAV) COGS-to-Revenue : 0.00 (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Navco Pharmaceuticals COGS-to-Revenue?

Navco Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2023 was C$0.00 Mil. Its Revenue for the three months ended in Mar. 2023 was C$0.00 Mil.

Navco Pharmaceuticals's COGS to Revenue for the three months ended in Mar. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Navco Pharmaceuticals's Gross Margin % for the three months ended in Mar. 2023 was N/A%.

Navco Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for Navco Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals COGS-to-Revenue Chart

Navco Pharmaceuticals Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

COGS-to-Revenue

Navco Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
COGS-to-Revenue	Get a 7-Day Free Trial														-	-	-	-	-

Navco Pharmaceuticals COGS-to-Revenue Calculation

Navco Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Jun. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Navco Pharmaceuticals's COGS to Revenue for the quarter that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Navco Pharmaceuticals (TSXV:NAV) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Navco Pharmaceuticals's Gross Margin % for the three months ended in Mar. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Navco Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Navco Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Navco Pharmaceuticals (TSXV:NAV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (TSXV:NAV) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7

Website

Navco Pharmaceuticals Inc uses of nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. The company's pipeline of applications is tailored to defend against pathogens utilizing new methods of action to capitalize on unmet product needs using natural & known compounds, nanoparticles, and no chemicals with a high degree of efficacy. Its target markets include human health & personal skin care, household & institutional products, and veterinary health.